{
    "eid": "2-s2.0-85127352330",
    "title": "A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines",
    "cover-date": "2022-04-20",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anti-SARS-CoV-2 IgG",
        "AZD1222",
        "Booster dose",
        "ChAdOx1 nCoV-19 vaccine",
        "CoronaVac vaccine",
        "Neutralizing antibody titer",
        "SARS-CoV-2 vaccine"
    ],
    "authors": [
        "Sira Nanthapisal",
        "Thanyawee Puthanakit",
        "Peera Jaru-Ampornpan",
        "Rapisa Nantanee",
        "Pimpayao Sodsai",
        "Orawan Himananto",
        "Jiratchaya Sophonphan",
        "Pintip Suchartlikitwong",
        "Narin Hiransuthikul",
        "Pornpimon Angkasekwinai",
        "Auchara Tangsathapornpong",
        "Nattiya Hirankarn"
    ],
    "citedby-count": 9,
    "ref-count": 31,
    "ref-list": [
        "Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants",
        "Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile",
        "CoronaVac induces lower neutralising activity against variants of concern than natural infection",
        "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",
        "Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells",
        "Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis",
        "Optimize Prime/Boost Vaccine Strategies: trained Immunity as a New Player in the Game",
        "Prime-boost vaccine strategy against viral infections: mechanisms and benefits",
        "Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination",
        "Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults",
        "Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population",
        "A serological assay to detect SARS-CoV-2 seroconversion in humans",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial",
        "Immunological memory cells",
        "Correlation of sample-to-cut-off ratio of anti-SARS-CoV-2 IgG antibody chemiluminescent assay with neutralization activity: a prospective multi-centric study in India",
        "Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial",
        "To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination",
        "WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic",
        "Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial",
        "Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: a randomized controlled trial",
        "Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60013939",
            "affilname": "Faculty of Medicine, Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013939",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60012521",
            "affilname": "Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012521",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "127904527",
            "affilname": "National Center for Genetic Engineering and Biotechnology (BIOTEC)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127904527",
            "affiliation-country": null
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Pediatric Infectious Diseases and Vaccines",
        "Chulalongkorn University Health Service Center",
        "Department of Microbiology, Faculty of Medicine, Chulalongkorn University",
        "HIV Netherlands Australia Thailand Research Collaboration",
        "Ratchadapisek Sompoch Endowment Fund",
        "Thai Red Cross AIDS Research Centre",
        "Department of Pediatrics",
        "Chulalongkorn University",
        "Thammasat University"
    ]
}